Novartis @Novartis · 28 Apr 2026
#Investors: Novartis delivered strong growth in priority brands and recent launches during Q1 2026, while US generic erosion weighed on results as expected. We remain on track to deliver our full year guidance. Press release: https://t.co/c3x8o96Gsf IR Webcast: https://t.co/u5UJehcvf6
4 233Views
22Likes
2Reposts
9Replies
0Quotes
4Bookmarks
Is that a lot?
1.02×vs this author's median4 132 views is typical
100Percentile for this authorof 3 recent posts
0.19×vs 100K–1M median22 159 views is typical
1.47%Reachviews ÷ followers
0.78%Engagement rateof viewers reacted